Skip to main content
Public offering could bring in $10M for OpGen

A public offering of common stock and common warrants has been priced by OpGen in hopes of raising $10 million. Net proceeds will be used to support general corporate functions, particularly the repayment of all outstanding bridge financing notes and the development of a one- to three-hour antibiotic resistance diagnostic product.

Full Story: